This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) rose 2.08% to $213.76 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&amp;P 500 Index falling 0.67% to 7,353.61 and Dow Jones Industrial Average falling 0.65% to 49,363.88.
The stock's rise snapped a two-day losing streak.
AbbVie Inc. closed 12.68% below its 52-week high of $244.81, which the company achieved on October 1st.
The stock outperformed some of its competitors Tuesday, as Johnson &amp; Johnson (JNJ) rose 0.47% to $230.00, Pfizer Inc. (PFE) rose 1.30% to $25.66, and Amgen Inc. (AMGN) rose 1.96% to $330.75.
Trading volume (7.1 M) eclipsed its 50-day average volume of 6.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 19, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-19-26 1632ET

ABBV

AbbVie Inc. (ABBV) shares rose 2.08% to $213.76 on a challenging trading day for the market, outperforming competitors like Johnson & Johnson and Pfizer. The stock ended 12.68% below its 52-week high of $244.81. Trading volume reached 7.1 million, surpassing the 50-day average of 6.9 million.

MarketWatch Automated

Abbvie

VG Health

VanEck Biotech ETF

SPDR S&P Biotech

First Trust NYSE Arca Biotech Index Fd

Invesco Nasdaq Biotechnology ETF

iShares Global Healthcare

iShares Biotechnology ETF

Ark Genomic Revolution ETF

Proshares Ultra Nasdaq Biotech

Direxion S&P Biotech Bull 3X

iShares US Pharma

Health Care Select Sector SPDR

ALPS Medical Breakthrough

Invesco Biotechnology & Genome ETF

S&P 500

Dow Jones Industrial Average

Johnson & Johnson

Pfizer

Amgen

Factset Research

AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day